Formalin-inactivated and alum-adjuvanted candidate vaccine + CpG 1018
/ Dynavax, Sinovac
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 09, 2020
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19
(clinicaltrials.gov)
- P1/2; N=552; Recruiting; Sponsor: Sinovac Research and Development Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease
August 07, 2020
Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)
(clinicaltrials.gov)
- P1/2; N=744; Active, not recruiting; Sponsor: Sinovac Research and Development Co., Ltd.; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Infectious Disease • Novel Coronavirus Disease
September 16, 2020
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19
(clinicaltrials.gov)
- P1/2; N=552; Not yet recruiting; Sponsor: Sinovac Research and Development Co., Ltd.
Clinical • New P1/2 trial • Infectious Disease • Novel Coronavirus Disease
1 to 3
Of
3
Go to page
1